Development and characterization of human fetal female reproductive tract organoids to understand Müllerian duct anomalies.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
26 07 2022
Historique:
entrez: 20 7 2022
pubmed: 21 7 2022
medline: 23 7 2022
Statut: ppublish

Résumé

Müllerian ducts are paired tubular structures that give rise to most of the female reproductive organs. Any abnormalities in the development and differentiation of these ducts lead to anatomical defects in the female reproductive tract organs categorized as Müllerian duct anomalies. Due to the limited access to fetal tissues, little is understood of human reproductive tract development and the associated anomalies. Although organoids represent a powerful model to decipher human development and disease, such organoids from fetal reproductive organs are not available. Here, we developed organoids from human fetal fallopian tubes and uteri and compared them with their adult counterparts. Our results demonstrate that human fetal reproductive tract epithelia do not express some of the typical markers of adult reproductive tract epithelia. Furthermore, fetal organoids are grossly, histologically, and proteomically different from adult organoids. While external supplementation of WNT ligands or activators in culture medium is an absolute requirement for the adult reproductive tract organoids, fetal organoids are able to grow in WNT-deficient conditions. We also developed decellularized tissue scaffolds from adult human fallopian tubes and uteri. Transplantation of fetal organoids onto these scaffolds led to the regeneration of the adult fallopian tube and uterine epithelia. Importantly, suppression of Wnt signaling, which is altered in patients with Müllerian duct anomalies, inhibits the regenerative ability of human fetal organoids and causes severe anatomical defects in the mouse reproductive tract. Thus, our fetal organoids represent an important platform to study the underlying basis of human female reproductive tract development and diseases.

Identifiants

pubmed: 35858415
doi: 10.1073/pnas.2118054119
pmc: PMC9335258
doi:

Substances chimiques

Ligands 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2118054119

Références

Development. 2017 May 15;144(10):1775-1786
pubmed: 28442471
Nat Commun. 2015 Dec 08;6:8989
pubmed: 26643275
Dis Model Mech. 2021 Jun 1;14(6):
pubmed: 34160006
Biol Reprod. 2009 Jun;80(6):1282-92
pubmed: 19176883
PLoS Genet. 2020 Mar 23;16(3):e1008664
pubmed: 32203505
Dev Biol. 2007 Jul 15;307(2):227-36
pubmed: 17532316
Plast Reconstr Surg. 1996 Apr;97(4):775-81; discussion 783-3
pubmed: 8628772
BMC Dev Biol. 2010 Dec 21;10:121
pubmed: 21176145
Front Cell Dev Biol. 2021 Apr 20;9:661472
pubmed: 33959613
Plast Reconstr Surg. 1994 Oct;94(5):727-31
pubmed: 7938301
Dev Biol. 2007 Jun 15;306(2):493-504
pubmed: 17467685
Annu Rev Anim Biosci. 2019 Feb 15;7:125-147
pubmed: 30183326
Endocr Rev. 2018 Oct 1;39(5):664-675
pubmed: 29901737
J Clin Diagn Res. 2017 Jul;11(7):TC30-TC35
pubmed: 28893003
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
J Clin Endocrinol Metab. 2020 Mar 1;105(3):
pubmed: 31614364
Differentiation. 2017 Sep - Oct;97:9-22
pubmed: 28918284
Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19272-7
pubmed: 20974921
Hum Reprod. 1997 Jul;12(7):1372-6
pubmed: 9262259
Cell Rep. 2013 Oct 31;5(2):421-32
pubmed: 24139799
N Engl J Med. 2004 Aug 19;351(8):792-8
pubmed: 15317892
PLoS One. 2013;8(4):e60148
pubmed: 23577087
Sex Dev. 2019;13(1):26-34
pubmed: 30504698
Dev Biol. 2016 Apr 15;412(2):234-49
pubmed: 26934381
EMBO J. 2020 Feb 3;39(3):e102771
pubmed: 31867777
Biomolecules. 2020 Sep 03;10(9):
pubmed: 32899226
Differentiation. 2018 Sep - Oct;103:46-65
pubmed: 30236463
Sex Dev. 2014;8(5):281-96
pubmed: 25033758
FEBS Open Bio. 2012 Mar 05;2:26-31
pubmed: 23650577
Nat Rev Mater. 2021;6(5):402-420
pubmed: 33623712
Hum Reprod Update. 2021 Jan 4;27(1):1-26
pubmed: 33395479
Dev Cell. 2005 Aug;9(2):283-92
pubmed: 16054034
J Assoc Res Otolaryngol. 2014 Oct;15(5):755-66
pubmed: 24942706
Ann Transl Med. 2020 Sep;8(17):1049
pubmed: 33145268
Am J Physiol Gastrointest Liver Physiol. 2020 Sep 1;319(3):G375-G381
pubmed: 32658619
Nat Cell Biol. 2017 May;19(5):568-577
pubmed: 28394884
Nat Rev Genet. 2003 Dec;4(12):969-80
pubmed: 14631357
Cell Rep. 2020 Feb 4;30(5):1463-1477.e7
pubmed: 32023462
Dev Dyn. 2016 Mar;245(3):307-22
pubmed: 26638186
Endocrinology. 2001 Jun;142(6):2167-72
pubmed: 11356658
Cell Stem Cell. 2021 Nov 4;28(11):1907-1921.e8
pubmed: 34343491
Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23952-23959
pubmed: 32900950
Development. 1998 Aug;125(16):3201-11
pubmed: 9671592
Dev Biol. 2005 Dec 1;288(1):276-83
pubmed: 16256976
Am J Hum Genet. 2009 Feb;84(2):197-209
pubmed: 19200523
Cell Stem Cell. 2013 Dec 5;13(6):734-44
pubmed: 24139758
Differentiation. 2008 Jul;76(6):578-86
pubmed: 18557761
Cell Stem Cell. 2021 Aug 5;28(8):1380-1396.e6
pubmed: 33852917
Am J Physiol Lung Cell Mol Physiol. 2004 Apr;286(4):L650-7
pubmed: 12818891
Dev Biol. 2017 Mar 15;423(2):138-151
pubmed: 28153546
Obstet Gynecol. 2018 Jan;131(1):e35-e42
pubmed: 29266078
Biol Reprod. 2019 Jan 1;100(1):49-60
pubmed: 30010727
Endocrinology. 2019 Oct 1;160(10):2282-2297
pubmed: 31290979
Development. 2017 Sep 1;144(17):3031-3041
pubmed: 28743800
J Gynecol Surg. 1992 Spring;8(1):25-30
pubmed: 10149787
Nat Rev Genet. 2018 Nov;19(11):671-687
pubmed: 30228295
Proc Natl Acad Sci U S A. 2017 Feb 7;114(6):E1018-E1026
pubmed: 28049832
Development. 2011 May;138(10):1967-75
pubmed: 21490063
Sci Adv. 2021 Jul 28;7(31):
pubmed: 34321199
Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16142-7
pubmed: 20805501
Nat Med. 2020 Oct;26(10):1593-1601
pubmed: 32895569
Hum Mol Genet. 2016 Mar 15;25(6):1059-73
pubmed: 26721931
Acta Biomater. 2015 Sep;23 Suppl:S17-26
pubmed: 26235342
Dev Biol. 2001 Dec 1;240(1):194-211
pubmed: 11784056
Hum Reprod. 1997 Oct;12(10):2277-81
pubmed: 9402295
Nat Genet. 2011 Jan;43(1):72-8
pubmed: 21131972
Gut. 2015 Jun;64(6):911-20
pubmed: 25007816
Hum Reprod. 2004 Jul;19(7):1629-32
pubmed: 15155602
Cell Stem Cell. 2020 Jan 2;26(1):64-80.e13
pubmed: 31883834
Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2118054119
pubmed: 35858415

Auteurs

Varshini D Venkata (VD)

School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia.
Cancer Detection and Therapy Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia.

M Fairuz B Jamaluddin (MFB)

School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia.
Cancer Detection and Therapy Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia.

Jyoti Goad (J)

School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia.
Cancer Detection and Therapy Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia.

Hannah R Drury (HR)

School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia.
Cancer Detection and Therapy Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia.

Melissa A Tadros (MA)

School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia.
Cancer Detection and Therapy Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia.

Rebecca Lim (R)

School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia.
Cancer Detection and Therapy Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia.

Ajay Karakoti (A)

Cancer Detection and Therapy Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia.
Global Innovative Center for Advanced Nanomaterials, School of Engineering, University of Newcastle, Callaghan, NSW 2308, Australia.

Rachel O'Sullivan (R)

Hunter New England Centre for Gynaecological Cancer, John Hunter Hospital, New Lambton Heights, NSW 2305, Australia.

Yvette Ius (Y)

Hunter New England Centre for Gynaecological Cancer, John Hunter Hospital, New Lambton Heights, NSW 2305, Australia.

Kenneth Jaaback (K)

Hunter New England Centre for Gynaecological Cancer, John Hunter Hospital, New Lambton Heights, NSW 2305, Australia.

Pravin Nahar (P)

Department of Maternity and Gynaecology, John Hunter Hospital, New Lambton Heights, NSW 2305, Australia.

Pradeep S Tanwar (PS)

School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia.
Cancer Detection and Therapy Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH